NeueHealth
NeueHealth runs value based care and ACO REACH programs for primary care providers, now private under NEA.
On the record
Checkpoint: ACO REACH program ends with no confirmed successor model funded
The call
NeueHealth survives on CMS contracts set to expire in 2026 while much larger rivals already run the same business at scale.
NeueHealth helps doctor groups manage patient care and get paid by insurance companies through a government program called ACO REACH. The problem is that much larger competitors like UnitedHealth and CVS already dominate this space at hundreds of times NeueHealth's size, and that main government program shuts down at the end of 2026 with no backup plan confirmed yet. Meanwhile, software that automates the paperwork and scheduling that NeueHealth does could replace much of what the company offers, and NeueHealth has not shown any special technology that would protect it from that threat. The one thing that matters: whether NeueHealth can move its doctor clients to a new government program (MSSP or LEAD) before 2026 ends without losing most of its revenue, which is something that has to happen in the next few years to keep the company alive.
Why
01
AI pressure: None apparent. AI tools for prior authorization, risk coding, and care scheduling can automate the core work NeueSolutions sells to providers. Could AI do the core job? Yes, likely.
02
Bigger players: UnitedHealth/Optum and CVS/Aetna. Optum and CVS Health already run value based primary care at vastly larger scale and can absorb providers NeueHealth loses. Could a giant copy it? Yes, easily.
03
What protects it. Existing CMS contracts and provider relationships give it a head start, but nothing stops Optum or CVS from taking the same providers.
What would change this call
Whether NeueSolutions announces a confirmed MSSP or LEAD migration with capitated lives before ACO REACH ends in 2026. Shows whether the core revenue line has a real successor or simply disappears.
Whether NeueHealth reports two consecutive quarters of revenue growth (not just EBITDA) under NEA ownership. Shows whether the business is actually growing again or just being cost-cut.
Further headcount reductions or divestitures reported in the 12 months after the October 2025 take-private close. Shows whether NEA is restructuring for a turnaround or shrinking the company further.
Whether NeueHealth reports two consecutive quarters of revenue growth (not just EBITDA) under NEA ownership. Shows whether the business is actually growing again or just being cost-cut.
Further headcount reductions or divestitures reported in the 12 months after the October 2025 take-private close. Shows whether NEA is restructuring for a turnaround or shrinking the company further.
Key numbers
- Revenue fell to $890.4M LTM, down 13.8% YoY
- Taken private by NEA at $1.465B enterprise value
- Headcount down 35% since 2023
Named risks
- ACO REACH program sunsets in 2026 with no confirmed successor revenue for NeueSolutions.
- Revenue declining (LTM down 13.8% YoY as of Q2 2025) despite EBITDA gains driven by cost cuts.
- Headcount down 35% since 2023 alongside negative and declining employee sentiment.
- Unresolved shareholder litigation over NEA buyout fairness opened Dec 2024 to Feb 2025.
- No proprietary AI or data moat identified against giants automating prior authorization and coding.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| UnitedHealth Group/Optum | losing to | 2024 revenue $400.3B vs NeueHealth's $936.7M, dominates value-based primary care at scale |
| CVS Health/Aetna/Oak Street | losing to | CVS acquired Oak Street for ~$10.6B EV in 2023, embedding scale NeueHealth lacks |
| Agilon Health, Privia Health, Aledade | contesting | Similarly-sized provider-enablement peers competing for same ACO/Medicare risk contracts as of 2025-2026 |
Questions people ask
- Is NeueHealth profitable in 2026?
- As a private company since October 2, 2025, NeueHealth no longer files public results. Its last reported figure was FY2024 Adjusted EBITDA of $22.5 million, its first sustained profitable streak, while consolidated revenue fell to $936.7 million from $1.16 billion in 2023.
- Who owns NeueHealth now?
- NeueHealth is owned by an affiliate of New Enterprise Associates (NEA), which has invested in the company since 2016. The take-private deal closed October 2, 2025 at a final enterprise value of about $1.465 billion, ending its run as a NYSE-listed company (NEUE).
- Is NeueHealth's revenue growing or shrinking?
- Shrinking. As of Q2 2025, NeueHealth's trailing-twelve-month revenue was about $890.4 million, down 13.8% year over year, per its August 6, 2025 earnings release, continuing a decline from $1.16 billion in 2023 to $936.7 million in 2024.
- Could AI replace NeueHealth's core business functions?
- Core NeueSolutions tasks like prior authorization, risk-adjustment coding, and care outreach are prime targets for healthcare AI automation, a $1.4 billion 2025 market per Menlo Ventures. As of July 2026 no NeueHealth-specific AI product had been identified in its own communications.
- What happens to NeueHealth's ACO REACH revenue after 2026?
- CMS's ACO REACH model, a major NeueSolutions revenue source, runs only through 2026 and is closed to new applicants as of July 2026. No confirmed successor program (like MSSP or LEAD) with locked-in capitated lives has been announced for NeueHealth.
- Who is NeueHealth's biggest competitor?
- UnitedHealth Group/Optum and CVS Health/Aetna dominate value-based primary care at far greater scale; UnitedHealth alone posted $400.3 billion in 2024 revenue versus NeueHealth's $936.7 million. Smaller peers Agilon, Privia, and Aledade compete for similar provider-enablement contracts.
Timeline
- 2026-06-29Revelio Labs reports headcount at 948 (Dec 2025), down 35% since 2023
- 2025-10-02Take-private transaction with NEA closes at ~$1.465B enterprise value
- 2025-08-06Q2 2025 results show LTM revenue $890.4M, down 13.8% YoY
- 2025-03-20FY2024 results: revenue $936.7M, Adjusted EBITDA $22.5M
- 2025-02-07Law firms continue investigating fairness of NEA buyout
- 2024-12-23Agreement to be taken private by NEA at ~$1.3B EV, $7.33/share
- 2024-01-16Bright Health Group rebrands as NeueHealth
- 2023-12-28California Medicare Advantage business sale announced, closing ~Jan 2024
Revision history
22 July 2026
First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Bright Health Group Adopts NeueHealth as Corporate Brand Name (2024-01-16)
- NeueHealth to Be Taken Private by NEA and Consortium of Investors (2024-12-22)
- NeueHealth Announces Closing of Take-Private Transaction (2025-10-01)
- Who Owns NeueHealth Company? (2025-11-02)
- NeueHealth Inc (NEUE) Q4 2024 Earnings Call Highlights (2025-03-20)
- NeueHealth Reports Fourth Quarter and Full Year 2024 Results (PDF) (2025-03-20)
- NeueHealth Reports Second Quarter 2025 Results (2025-08-06)
- NeueHealth Number of Employees 2026 (2026-06-29)
- Bright Health Group Strengthens Capital Position... (2023-12-28)
- ACO REACH Model (2026-07-09)
- Oak Street Health -> History (2026-07-22)
- 2025: The State of AI in Healthcare (2026-07-09)